Synthesis of ¹³¹I-Labeled Glucose-Conjugated Inhibitors of O⁶-Methylguanine-DNA Methyltransferase (MGMT) and Comparison with Nonconjugated Inhibitors as Potential Tools for in Vivo MGMT Imaging

Abstract

O(6)-Substituted guanine derivatives are powerful agents used for tumor cell sensitization by inhibition of the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT). To provide targeted accumulation of MGMT inhibitors in tumor tissue as well as tools for in vivo imaging, we synthesized iodinated C(8)-alkyl-linked glucose conjugates of 2-amino-6-(5-iodothenyl)-9H-purine (O(6)-(5-iodothenyl) guanine, ITG) and 2-amino-6-(3-iodobenzyloxy)-9H-purine (O(6)-(5-iodobenzyl) guanine, IBG). These compounds have MGMT inhibitor constants (IC(50) values) of 0.8 and 0.45 microM for ITGG and IBGG, respectively, as determined in HeLa S3 cells after 2-h incubation with inhibitor. To substantiate that the (131)I-(hetero)arylmethylene group at the O(6)-position of guanine is transferred to MGMT, both the glucose conjugated inhibitors ITGG and IBGG and the corresponding nonglucose conjugated compounds ITG and IBG were labeled with iodine-131. The radioiodinations of all compounds with [(131)I]I(-) were performed with radiochemical yields of >70% for the destannylation of the corresponding tri-n-butylstannylated precursors. The binding ability of [(131)I]ITGG, [(131)]IBGG, [(131)I]ITG, and [(131)I]IBG to purified MGMT was tested. All radioactive compounds were substrates for MGMT, as demonstrated using a competitive repair assay. The newly synthesized radioactive inhibitors were utilized to study ex vivo biodistribution in mice, and the tumor-to-blood ratio of tissue uptake of [(131)I]IBG and [(131)I]IBGG was determined to be 0.24 and 0.76 after 0.5 h, respectively.

Lack of activation of UCP1 in isolated brown adipose tissue mitochondria by glucose-O-ω-modified saturated fatty acids of various chain lengths

“…Chromatography (1:9 MeOH-CH 2 Cl 2 ) gave 1a (27 mg, 81 %) as a white solid; IR (film) cm Preparation of alkyltriphenylphosphonium bromides (6c-e) [23] 6-Bromohexan-1-ol 5c (687 mg, 3.79 mmol) and triphenylphosphine (994 mg, 3.79 mmol) were dissolved in CH 3 CN (10 mL) and the mixture was heated at reflux for 4 days. The solvent was removed to give 6c as a translucent hygroscopic solid, which was used in the next step without further purification; 31 P NMR (CDCl 3 , 161 MHz): δ 24.5; ES-HRMS calculated for C 24 13 C data were in good agreement with that reported previously [24].…”

Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy

“…Thus, β-particles are considered to be most suitable for the treatment of bulky or large volume tumors via the "crossfire effect". [10,134] However, the long range of β-particles may produce nonspecific cytotoxic effects by destroying surrounding normal cells. [10,134] However, the long range of β-particles may produce nonspecific cytotoxic effects by destroying surrounding normal cells.…”

Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs)

“…Attempts to attach the glucose moieties onto 6 employing peracetyl-protected glucosyl donors led predominately to acetylation of the primary hydroxyl groups of the substrate. The glycosidation of 6 was finally achieved through the use of the perbenzoyl-protected trichloroacetimidate 7 22 under the influence of TMSOTf, furnishing a diastereomeric mixture of inseparable bis -β-glucosides (88% combined yield, 1:1 dr ). Cleavage of the benzyl ethers by hydrogenolysis provided a mixture of diastereomeric bis -phenols (86% yield, 1:1 dr ) which proved separable by preparative thin layer chromatography (PTLC, multiple elutions) to afford pure ( S , S )- 8 and ( R , R )- 9 .…”